The OBP2A Antibody Market Size was valued at USD 102.9 Mn in 2023 and is predicted to reach USD 419.0 Mn by 2031 at a 19.5% CAGR during the forecast period for 2024-2031. An OBP2A antibody is a special kind of antibody that can identify and bind to the OBP2A protein. The OBP2A antibody market is poised for growth due to the favorable conditions created by the global expansion of the biomedical and pharmaceutical industries. Furthermore, as tar...
Report ID: 2590 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
The Zearalenone Antibody Market Size was valued at USD 11.8 Mn in 2023 and is predicted to reach USD 45.4 Mn by 2031 at an 18.7% CAGR during the forecast period for 2024-2031. Zearalenone antibodies can detect and bind to the mycotoxin zearalenone that fusarium produces. Several different Assays and diagnostic tests use the antibody to identify and quantify zearalenone in food and feed samples. This helps to ensure that agricultural and food s...
Report ID: 2591 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 170
The Gene Switch / Molecular Switch Market Size is valued at USD 0.69 Bn in 2023 and is predicted to reach USD 1.44 Bn by the year 2031 at an 9.9% CAGR during the forecast period for 2024-2031. Gene switches are locations on genes that are capable of binding regulatory molecules to start the transcription and translation processes that result in the expression of that particular gene. Gene switching pertains to the reversible on/off regulation ...
Report ID: 2595 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 168
The Recombinant Human Endostatin Market Size is valued at USD 133.3 Mn in 2023 and is predicted to reach USD 249.4 Mn by the year 2031 at a 8.3% CAGR during the forecast period for 2024-2031. Recombinant human endostatin is a naturally occurring protein in the human body that prevents angiogenesis and has been bioengineered. Genetic engineering methods are used to generate the recombinant form for medical uses. The increasing number of cancer ...
Report ID: 2597 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 170
The Periodontal Therapeutics Market Size was valued at USD 843.6 Mn in 2023 and is predicted to reach USD 1,497.4 Mn by 2031 at a 7.6% CAGR during the forecast period for 2024-2031. Periodontal disease encompasses a wide range of inflammatory conditions affecting the tissues surrounding the teeth. It primarily includes gingivitis (mild inflammation of the gums) and periodontitis (severe inflammation that can lead to tooth loss). Gingivitis is ...
Report ID: 2576 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 175
Radionuclide Drug Conjugates (RDC) Market Size is predicted to witness a 13.9% of CAGR during the forecast period for 2024-2031. Radionuclide Drug Conjugates (RDCs) represent a promising innovation in cancer treatment, utilizing a targeted approach to deliver radiation directly to tumor cells. By combining a radionuclide, targeting molecule, chelator, and linker, RDCs minimize harm to healthy tissues while effectively attacking cancer. This ta...
Report ID: 2567 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Disseminated Intravascular Coagulation (DIC) Market Size is valued at USD 437.3 Mn in 2023 and is predicted to reach USD 563.8 Mn by the year 2031 at a 3.3% CAGR during the forecast period for 2024-2031. The Disseminated Intravascular Coagulation (DIC) market focuses on managing a serious condition characterized by abnormal blood clotting, involving key segments such as diagnostics (e.g., D-dimer tests), therapeutics (anticoagulants and blood ...
Report ID: 2573 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Global Long Acting Drug Delivery Technologies Services Market Size is valued at USD 13.7 Bn in 2023 and is predicted to reach USD 30.2 Bn by the year 2031 at a 10.6% CAGR during the forecast period for 2024-2031. The global long-acting drug delivery technologies and services market is witnessing robust growth due to the demand for improved patient adherence and therapeutic outcomes. Long-acting formulations, including injectables and implants,...
Report ID: 2565 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Cytotoxic Drugs and HPAPI Manufacturing Market Size is valued at USD 10.7 Bn in 2023 and is predicted to reach USD 27.1 Bn by the year 2031 at an 12.5% CAGR during the forecast period for 2024-2031. Cytotoxic drugs and high-potency active pharmaceutical ingredients (HPAPIs) are essential components in modern medicine, known for their potent biological activity at low concentrations. They are instrumental in treating cancers, respiratory ailmen...
Report ID: 2557 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year 2031 at an 5.13% CAGR during the forecast period for 2024-2031. Insulin-like growth factors (IGFs) are proteins that resemble insulin in structure and share some of its effects. Their primary function, however, is to stimulate cell growth and development throughout the body, forming part of a complex system known as the ...
Report ID: 2561 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Pharmaceuticals